S. Gupta et al., Dissection of ras-dependent signaling pathways controlling aggressive tumor growth of human fibrosarcoma cells: Evidence for a potential novel pathway, MOL CELL B, 20(24), 2000, pp. 9294-9306
Activation of multiple signaling pathways is required to trigger the full s
pectrum of in vitro and in vivo phenotypic traits associated with neoplasti
c transformation by oncogenic Ras, To determine which of these pathways are
important for N-ras tumorigenesis in human cancer cells and also to invest
igate the possibility of cross talk among the pathways, we have utilized a
human fibrosarcoma cell line (HT1080), which contains an endogenous mutated
allele of the N-ras gene, and its derivative (MCH603c8), which lacks the m
utant N-ras allele, We have stably transfected MCH603c8 and HT1080 cells wi
th activating or dominant-negative mutant cDNAs, respectively, of various c
omponents of the Raf, Rac, and RhoA pathways, In previous studies with thes
e cell lines we showed that loss of mutant Ras function results in dramatic
changes in the in vitro phenotypic traits and conversion to a weakly tumor
igenic phenotype in vivo, We report here that only overexpression of activa
ted MEK contributed significantly to the conversion of MCH603c8 cells to an
aggressive tumorigenic phenotype. Furthermore, we have demonstrated that b
locking the constitutive activation of the Raf-MEK Rac, or RhoA pathway alo
ne is not sufficient to block the aggressive tumorigenic phenotype of HT108
0, despite affecting a number of in vitro-transformed phenotypic traits, We
have also demonstrated the possibility of bidirectional cross talk between
the Raf-MEK-ERK pathway and the Rac-JNK or RhoA pathway, Finally, overexpr
ession of activated MEK in MCH603c8 cells appears to result in the activati
on of an as-yet-unidentified target(s) that is critical for the aggressive
tumorigenic phenotype.